正體中文
About Us
News
Products
Technology Platform
Products
Production
Investors
Contact Us
News
Home
News
News
Intech made co-development alliance with Twi to enter niche inhaler market of US.
2017/04/26
Intech got the permission of clinical trials for its asthma product Duasma in China.
2016/10/26
Intech got the preliminary approval and will submit the application of final approval for listing on OTC stock market soon.
2016/09/09
Intech has submitted its application for IPO, and triggered its multinational clinical trials and international business development.
2016/04/29
Intech new plant accelerates the pace and expands the capacity to fulfill the international market demand.
2015/12/23
Intech signed the license and supply agreement with China Resources Saike Pharmaceutical, both companies will form an alliance and seize the niche market.
2015/12/02
Intech iLEF MDI platform is praised widely and will move quickly in China market.
2015/10/22
Intech got the qualification report of sample testing for Duasma, an inhaler product treating Asthma, and accelerate the market expansion in Taiwan and China.
2015/09/21
Intech got the license of Duasma, an inhaler product treating Asthma, in Hong Kong and accelerate the market expansion in the area of Greater China.
2015/05/11
Intech has launched a reliever drug of asthma Synvent in Taiwan and targets the 2.6 billion global market in the future.
2015/04/07
1
2
亚盈官方入口
|
冠盈体育(中国)有限公司
|
下注官网 - 网站(中国)集团有限公司
|
天博网页版
|
天博官方官网
|
开云网页版入口(中国)开云股份有限公司
|
开云电子app下载中国有限公司
|
18新利【中国】有限公司官网
|
开元体育(中国)开元股份有限公司
|